Crossovers back Xeris in $41M series C

Xeris Pharmaceuticals Inc. (Austin, Texas) raised $41 million in a series C round led by Redmile Group. New investors Deerfield and Sabby Capital also participated, as did The McNair Group and other existing investors. Evercore acted as the round's placement agent. ...